In this episode Dr. Blevins reviews the physiological factors that regulate the secretion of Growth Hormone and discusses tests to evaluate disorders in its secretion.
Pituitary 101: Episode 8
March 21, 2025
Acromegaly
Acromegaly is usually caused by a noncancerous tumor. Middle-aged adults are most commonly affected. Symptoms include enlargement of the face, hands, and feet. Prompt treatment is needed to avoid serious illness. Drugs can reduce the effects of growth hormone. If needed, surgery and radiation may be used to remove tumor cells.
Acromegaly: a discussion about psychological and emotional health support initiatives
February 27, 2025
Today's podcast is about an important Chiesi Rare Diseases initiative to learn more about the psychological, social, and emotional health issues facing acromegaly patients. We talked to Stuart Siedman, Chiesi's Vice President of advocacy. Stuart
Two leading acromegaly experts discuss promising treatment options
January 7, 2025
In today's podcast, we are excited to welcome Dr. Joanna Spencer-Segal, a research assistant professor at the Michigan Neuroscience Institute and an assistant professor in the Department of Internal Medicine, Division of Metabolism, Endocrinology, and
Pituitary Grand Rounds, Episode 6: Controversies in the Management of Acromegaly
December 2, 2024
This fantastic presentation by Dr. John Carmichael, Distinguished Professor of Clinical Medicine at the University of Southern California and Co-director of the USC Pituitary Center focuses on the controversies arising from the clinical dilemmas present in treating a complicated condition like acromegaly.
Machine learning technology promises early diagnosis for acromegaly
October 31, 2024
SAN FRANCISCO, BARCELONA, TORONTO – October 31, 2024 – Artificial Intelligence (AI) could play a significant role in aiding the diagnosis of rare diseases. This is especially true for facial recognition and machine learning in
Musings on Tea and Acromegaly in Connemara
October 24, 2024
From J D Faccinetti, co-founder – It is often said that once you know people with acromegaly, you will see it more often. It makes you wonder how apt the definition of “rare” is for
Renaming Acromegaly: Time for a Fresh Identity?
August 27, 2024
From the desk of Jorge D Faccinetti, co-founder: I can’t help but think that raising awareness for acromegaly would be easier with a different name. My branding instincts tell me that this name is doing
Acromegaly: direct and personal
May 29, 2024
Life with acromegaly can be a daunting experience, especially if it's not diagnosed early and adequately. A whole set of related conditions can take hold, making everyday life a challenge, to say the least. A
Rethink Acromegaly: A new resource for patients and healthcare professionals
April 5, 2024
With the lead line of “There is more to my acromegaly than just numbers on a page” comes a new informational website from the Chiesi Global Rare Diseases patient support group. Rethink Acromegaly is a
Pituitary genetics, acromegaly, and Irish giants
February 19, 2024
Reading about each of these famous giants prompted me to dig a bit more to see if there was anything new to report on the genetics of pituitary adenomas. Here’s the latest.
A remarkable acromegaly story of transformation.
February 7, 2024
Today’s podcast is about our super athlete friend Risa August and her new book about her acromegaly experience, her life, and her 1,800 mile ride from Canada to Mexico.
Somavert turns twenty: the pegvisomant story
December 27, 2023
From J D Faccinetti, Co-founder and Chief Editor – When you deal with a chronic pituitary disease, you get close to your medications, just like you would to a friend. This was my experience with
Our Chat with Crinetics CEO Dr. Scott Struthers.
September 21, 2023
Today, Dr. Scott Struthers talks to PWN about paltusotine, their new once-a-day oral drug candidate, which recently completed phase 3 of the clinical trial.